EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 132 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $16,663,000 | +41.0% | 458,398 | +56.2% | 0.03% | +38.1% |
| Q4 2015 | $11,821,000 | +127.1% | 293,461 | +60.6% | 0.02% | +110.0% |
| Q3 2015 | $5,206,000 | -3.5% | 182,742 | +11.6% | 0.01% | +11.1% |
| Q2 2015 | $5,394,000 | +34.1% | 163,693 | +17.0% | 0.01% | +28.6% |
| Q1 2015 | $4,022,000 | -21.0% | 139,861 | -25.4% | 0.01% | -22.2% |
| Q4 2014 | $5,090,000 | +19.8% | 187,605 | -6.0% | 0.01% | +12.5% |
| Q3 2014 | $4,250,000 | -25.2% | 199,484 | -21.1% | 0.01% | -20.0% |
| Q2 2014 | $5,679,000 | -5.9% | 252,854 | +5.9% | 0.01% | -9.1% |
| Q1 2014 | $6,032,000 | +172.6% | 238,698 | +151.9% | 0.01% | +175.0% |
| Q4 2013 | $2,213,000 | -29.9% | 94,759 | -42.8% | 0.00% | -33.3% |
| Q3 2013 | $3,155,000 | +14.6% | 165,566 | -13.3% | 0.01% | +20.0% |
| Q2 2013 | $2,754,000 | – | 190,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |